BASTA JAMES - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 4, 2024, BASTA JAMES's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (EVP, General Counsel), and currently has 81,571 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NTLA insiders.
Data Source: SEC.
BASTA JAMES - Insider Non-Derivative Transactions of NTLA Common Stock
BASTA JAMES - Insider Non-Derivative Transactions at NTLA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 5, 2024 | Sell -- (Common Stock) | 2297 | 32.99 | 81571 |
| Mar 2, 2024 | Acquisition -- (Common Stock) | 32394 | 0 | 83868 |
| Jan 4, 2024 | Sell -- (Common Stock) | 3805 | 29.46 | 51474 |
| Mar 3, 2023 | Sell -- (Common Stock) | 1088 | 43.88 | 55279 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 24539 | 0 | 44098 |
| Mar 2, 2023 | Acquisition -- (Common Stock) | 12269 | 0 | 56367 |
| Jan 5, 2023 | Sell -- (Common Stock) | 1138 | 37.21 | 19559 |